Christopher Pearce
Overview
Explore the profile of Christopher Pearce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
593
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jung M, Xia T, Ilomaki J, Pearce C, Nielsen S
Pain Med
. 2024 Jan;
25(4):263-274.
PMID: 38191211
Objective: To identify common opioid tapering trajectories among patients commencing opioid taper from long-term opioid therapy for chronic non-cancer pain and to examine patient-level characteristics associated with these different trajectories....
12.
Jung M, Xia T, Ilomaki J, Pearce C, Nielsen S
Pain
. 2023 Dec;
165(6):1327-1335.
PMID: 38112755
Current research indicates that tapering opioids may improve pain and function in patients with chronic noncancer pain. However, gaps in the literature remain regarding the choice of opioid and nonopioid...
13.
Prgomet M, Hardie R, Sezgin G, Thomas J, Pearce C, McGuire P, et al.
Stud Health Technol Inform
. 2023 Oct;
309:257-261.
PMID: 37869853
The COVID-19 pandemic necessitated a shift in the delivery of patient care, with telehealth rapidly scaled to facilitate access to care while reducing risks of COVID-19 transmission. In this paper,...
14.
Xia T, Picco L, Lalic S, Buchbinder R, Bell J, Andrew N, et al.
JMIR Res Protoc
. 2023 Oct;
12:e51825.
PMID: 37847553
Background: Increasing harms related to prescription opioids over the past decade have led to the introduction of a range of key national and state policy initiatives across Australia. These include...
15.
Picco L, Xia T, Bell J, Pearce C, Buchbinder R, Lubman D, et al.
Drug Alcohol Rev
. 2023 Oct;
42(7):1639-1646.
PMID: 37798947
Introduction: Prescription drug monitoring programs (PDMP) are increasingly used to identify people prescribed high-dose opioids. However, little is known about whether PDMPs impact opioid agonist treatment (OAT) uptake, the gold...
16.
Haas R, Gorelik A, OConnor D, Pearce C, Mazza D, Buchbinder R
Arthritis Care Res (Hoboken)
. 2023 Jul;
77(3):402-411.
PMID: 37403274
Objective: The aim of this study was to examine imaging requested by general practitioners (GPs) for patients with low back, neck, shoulder, and knee complaints over 5 years (2014-2018). Methods:...
17.
Kamalakkannan A, Sezgin G, McLeod A, Pearce C, Georgiou A, Prgomet M, et al.
Stud Health Technol Inform
. 2023 Jun;
304:124-125.
PMID: 37347585
Major challenges exist in identifying Long COVID patients from diagnosis texts recorded by general practitioners. A classification framework is proposed that can be used to identify Long COVID patients given...
18.
Nielsen S, Picco L, Russell G, Pearce C, Andrew N, Lubman D, et al.
Int J Drug Policy
. 2023 May;
117:104053.
PMID: 37209441
Background: Australian prescription drug monitoring programs (PDMPs) provide information about a patient's recent medication history for controlled drugs at the point of prescribing and dispensing. Despite their increasing use, the...
19.
Nielsen S, Buchbinder R, Pearce C, Lubman D, Lalic S, Haas R, et al.
BMJ Open
. 2023 May;
13(5):e067746.
PMID: 37130678
Purpose: The OPPICO cohort is a population-based cohort based on non-identifiable electronic health records routinely collected from 464 general practices in Victoria, Australia, created with the aim of understanding opioid...
20.
Hardie R, Sezgin G, Pont L, Thomas J, Prgomet M, McGuire P, et al.
Med J Aust
. 2023 Apr;
219(1):26-27.
PMID: 37106508
No abstract available.